Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
Go back to Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development| StemCells, Inc. (NASDAQ: TEM) | Delayed: 51.94 +3.33 (6.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.61 | 52 Week High | $0.45 | |||
| Open | $48.62 | 52 Week Low | $0.37 | |||
| Day High | $52.56 | P/E | N/A | |||
| Day Low | $48.45 | EPS | $-0.31 | |||
| Volume | 6,959,949 | |||||
